4th Quarter - Report
TIBER CREEK GROUP for AMGEN INC
Firm
Client
Income
$80,000
Expenses
—
What was lobbied
One issue area, each in the filer's own words, with who lobbied on it and where.
Medicare/Medicaid MMM
Issues relating to Part D pricing reform. Issues relating to Part B pricing reform. S. 2543 - The Prescription Drug Price Reduction Act. H.R.3 - Lower Drug Costs Now Act of 2019. H.R.1865 Further Consolidated Appropriations Act, 2020 (Public Law No: 116-94)
| Lobbyist | Covered position, as disclosed |
|---|---|
| JOHN MICHAEL GONZALEZ | — |
| JAMES HEIMBACH | — |
| JONATHON JONES | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.